Ketodarolutamide is an investigational non-steroidal androgen receptor antagonist currently being studied for its potential in treating advanced prostate cancer. By acting as a potent antiandrogen, this… Read more
Ketodarolutamide is an investigational non-steroidal androgen receptor antagonist currently being studied for its potential in treating advanced prostate cancer. By acting as a potent antiandrogen, this compound works to block androgen signaling pathways within prostate tumor cells, offering a similar mechanism to its structural analogue, darolutamide. The range of Ketodarolutamide reference standards, including identified impurities, degradation products, metabolites, and stable isotope labelled compounds, supports critical analytical needs. These materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling and method validation. Using high-quality analytical standards allows researchers to accurately quantify drug levels, monitor potential degradation, and conduct precise quality control testing throughout the drug development lifecycle. Stable isotope labelled variants provide vital internal standards for mass spectrometry-based bioanalytical assays, ensuring reliability in pharmacokinetic and metabolic studies as the drug progresses through investigation.